Hinge Health Form 144: 600,613-share notice

Hinge Health, Inc. filed a Notice of Proposed Sale on Form 144 reporting proposed dispositions of Class A shares by Insight Venture Partners (Cayman) X, L.P.

Rhea-AI Filing Summary

Hinge Health, Inc. filed a Notice of Proposed Sale on Form 144 reporting proposed dispositions of Class A shares by Insight Venture Partners (Cayman) X, L.P. The filing lists multiple sale dates in June 2026 and a largest single entry of 600,613 shares on 06/29/2026 with a reported proceeds figure of $49,750,937.00.

The excerpt shows earlier June 2026 trades by the same holder ranging from 26,856 to 218,362 shares on separate dates, with reported dollar amounts for each line. The filing records a prior conversion event dated 07/03/2018 (Series B Preferred conversion) and notes shares were wired to the portfolio company.

Insights

Securities Compliance Attorney

Form 144 lists multiple proposed dispositions by an affiliate across June 2026.

The filing names Insight Venture Partners (Cayman) X, L.P. as the selling holder with separate proposed sale entries on 06/16/2026, 06/22/2026, 06/23/2026, 06/24/2026, 06/25/2026, and 06/29/2026

Form 144 is a regulatory notice required for affiliated sellers; the listed dollar amounts next to each line represent reported proceeds for those proposed dispositions. Subsequent SEC filings or broker reports would confirm whether the sales were executed and provide settlement details.

Key Figures

Largest line item: 600,613 shares Proceeds reported (largest line): $49,750,937.00 Sample prior June line: 218,362 shares +3 more

6 metrics

Largest line item 600,613 shares proposed disposition on 06/29/2026

Proceeds reported (largest line) $49,750,937.00 associated with 600,613 shares on 06/29/2026

Sample prior June line 218,362 shares proposed disposition on 06/24/2026

Other June line 217,442 shares proposed disposition on 06/25/2026

Earlier small line 26,856 shares proposed disposition on 06/16/2026

Series B conversion date 07/03/2018 Stock Conversion before IPO (Series B Preferred)

Key Terms

Form 144, Series B Preferred, Stock Conversion before IPO, Wired to portfolio company

4 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Series B Preferred financial

"Series B Preffered | 07/03/2018 | Stock Conversion before IPO"

Series B preferred is a class of ownership created during a later private funding round that gives investors special rights ahead of ordinary shareholders. Think of it like a priority ticket at a crowded exit: holders get paid or reimbursed before common shareholders if the company is sold or winds down, often receive fixed payments or protection against value loss, and typically have options to convert into regular shares; those features affect potential returns and control for investors.

Stock Conversion before IPO financial

"Stock Conversion before IPO | Hinge Health, Inc."

Wired to portfolio company technical

"07/03/2018 | Wired to portfolio company"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does HNGE's Form 144 disclose about the June 2026 sales?

The Form 144 lists multiple proposed dispositions by Insight Venture Partners (Cayman) X, L.P., dated June 16–29, 2026. The largest single line shows 600,613 shares on 06/29/2026 with proceeds of $49,750,937.00.

Who is the selling holder named on the Hinge Health Form 144?

The selling holder is identified as Insight Venture Partners (Cayman) X, L.P. The filing lists that entity's address and multiple line items detailing share counts and dollar amounts for proposed sales in June 2026.

Does the filing show how the shares were originally issued to the holder?

The excerpt references a Series B Preferred conversion dated 07/03/2018 described as 'Stock Conversion before IPO' and notes shares were 'Wired to portfolio company.' That conversion is the only origin detail shown in the excerpt.

Are the reported dollar amounts in the Form 144 the actual sale proceeds?

The filing lists dollar figures adjacent to each line item (for example, $49,750,937.00 for 600,613 shares). These figures are the reported proceeds on the notice; execution and final settlement would be confirmed in subsequent transaction records.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/07/2026 - 04:14 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001710860
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 MARKET STREET 7TH FLOOR SAN FRANCISCO CALIFORNIA 94105
Phone	415-689-8429
Name of Person for Whose Account the Securities are To Be Sold	Insight Venture Partners (Cayman) X, L.P.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	600613	54055170.00	54655926	07/07/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Series B Preffered	07/03/2018	Stock Conversion before IPO	Hinge Health, Inc.			4485644	07/03/2018	Wired to portfolio company

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Insight Venture Partners (Cayman) X, L.P. 1114 Avenue of the Americas 36th Floor New York NY 10036	Class A	06/16/2026	26856	1889577.42
Insight Venture Partners (Cayman) X, L.P. 1114 Avenue of the Americas 36th Floor New York, NY 10036	Class A	06/22/2026	91893	6520185.11
Insight Venture Partners (Cayman) X, L.P. 1114 Avenue of the Americas 36th Floor New York NY 10036	Class A	06/23/2026	46060	3234079.87
Insight Venture Partners (Cayman) X, L.P 114 Avenue of the Americas 36th Floor New York NY 10036	Class A	06/24/2026	218362	15550256.78
nsight Venture Partners (Cayman) X, L.P 114 Avenue of the Americas 36th Floor New York NY 10036	Class A	06/25/2026	217442	15617445.49
nsight Venture Partners (Cayman) X, L.P 14 Avenue of the Americas 36th Floor New York NY 10036	Class A	06/29/2026	600613	49750937.00

144: Remarks and Signature

Remarks
Date of Notice	07/07/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Rashida Mitchell, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Insight Venture Partners (Cayman) X,
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)